Synergetic hemostatic potential of fibrinogen γ‐chain peptide‐coated, adenosine 5′‐diphosphate‐encapsulated liposomes combined with whole blood transfusion: A preclinical study
Transfusion · 2026
DOI: 10.1111/trf.70034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2026. Verfasst von Osamu Ishida und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, National Defense Medical College, Tokorozawa, Japan. Hauptthemen laut MEDLINE: Liposomes, Adenosine Diphosphate, Fibrinogen, Blood Transfusion. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JPS KAKENHI.
Abstract (Originalsprache)
Background
Whole blood (WB) transfusions are being reevaluated because of their high hemostatic capacity and reduced volume. Fibrinogen γ‐chain peptide‐coated, adenosine 5′‐diphosphate (ADP)‐encapsulated liposomes are potent hemostatic adjuvants promoting platelet thrombi formation. This study aimed to elucidate the potential interactions between simultaneous WB transfusion and the administration of fibrinogen γ‐chain peptide‐coated ADP‐encapsulated liposomes. Study Design and Methods We used a rabbit model of postcardiopulmonary bypass (CPB) coagulopathy. One hour after CPB, the rabbits were transfused with WB (WB group, n = 7) or H12‐ADP‐liposomes along with WB transfusion (WB + H12‐ADP‐liposome group, n = 7). Blood cell counts, coagulation activity, platelet function, and bleeding time were evaluated.
Results
Hemoglobin concentration, platelet count, activated clotting time, and ADP and collagen test results were comparable between the WB + H12‐ADP‐liposome and WB groups after transfusion. However, bleeding time was remarkably reduced in the WB + H12‐ADP‐liposome group (378 ± 150 s) compared with that in the WB group (551 ± 255 s, p < .01), suggesting that H12‐ADP‐liposomes further enhanced the hemostatic effect of WB transfusion in post‐CPB coagulopathy.
Discussion
Administration of H12‐ADP‐liposomes along with WB transfusion had a synergistic effect on hemostatic performance, providing a greater therapeutic advantage than WB transfusion alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, National Defense Medical College, Tokorozawa, Japan.
- Department of Physiology, National Defense Medical College, Tokorozawa, Japan.
- Division of Traumatology, National Defense Medical College Research Institute, Tokorozawa, Japan.
- Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
- Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.
ORCID-Profile: Shinji Takeoka
Förderung
- JPS KAKENHI
Zitieren
APA
Ishida, O., Hagisawa, K., Yamanaka, N., Aoki, M., Tsutsumi, K., Takeoka, S., & Kinoshita, M. (2026). Synergetic hemostatic potential of fibrinogen γ‐chain peptide‐coated, adenosine 5′‐diphosphate‐encapsulated liposomes combined with whole blood transfusion: A preclinical study. Transfusion. https://doi.org/10.1111/trf.70034
Vancouver
Ishida O, Hagisawa K, Yamanaka N, Aoki M, Tsutsumi K, Takeoka S, et al. Synergetic hemostatic potential of fibrinogen γ‐chain peptide‐coated, adenosine 5′‐diphosphate‐encapsulated liposomes combined with whole blood transfusion: A preclinical study. Transfusion. 2026. doi:10.1111/trf.70034
BibTeX
@article{Ishida2026,
author = {Ishida, Osamu and Hagisawa, Kohsuke and Yamanaka, Nozomu and Aoki, Makoto and Tsutsumi, Koji and Takeoka, Shinji and Kinoshita, Manabu},
title = {Synergetic hemostatic potential of fibrinogen γ‐chain peptide‐coated, adenosine 5′‐diphosphate‐encapsulated liposomes combined with whole blood transfusion: A preclinical study},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70034}
}
EUVIMED